These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 10670449)

  • 1. Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced pain.
    Baulmann J; Spitznagel H; Herdegen T; Unger T; Culman J
    Neuroscience; 2000; 95(3):813-20. PubMed ID: 10670449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-FOS expression in the rat brain in response to substance P and neurokinin B.
    Spitznagel H; Baulmann J; Blume A; Unger T; Culman J
    Brain Res; 2001 Oct; 916(1-2):11-21. PubMed ID: 11597586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress.
    Culman J; Klee S; Ohlendorf C; Unger T
    J Pharmacol Exp Ther; 1997 Jan; 280(1):238-46. PubMed ID: 8996202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of tachykinin NK1/NK2 receptors in the brain attenuates the activation of corticotrophin-releasing hormone neurones in the hypothalamic paraventricular nucleus and the sympathoadrenal and pituitary-adrenal responses to formalin-induced pain in the rat.
    Culman J; Das G; Ohlendorf C; Haass M; Maser-Gluth C; Zuhayra M; Zhao Y; Itoi K
    J Neuroendocrinol; 2010 May; 22(5):467-76. PubMed ID: 20210847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of Fos-like immunoreactivity in guinea-pig brain following administration of the neurokinin-1 receptor agonist, [SAR9,MET(O2)11]substance P.
    Yip J; Chahl LA
    Neuroscience; 1999; 94(2):663-73. PubMed ID: 10579226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.
    Culman J; Wiegand B; Spitznagel H; Klee S; Unger T
    Br J Pharmacol; 1995 Mar; 114(6):1310-6. PubMed ID: 7542533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
    Tauer U; Zhao Y; Hunt SP; Culman J
    Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: characterization with tachykinin antagonists.
    Michaud N; Couture R
    Neuropeptides; 2003 Dec; 37(6):345-54. PubMed ID: 14698677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
    Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
    Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of Fos-like immunoreactivity induced by the NK3 tachykinin receptor agonist, senktide, in the guinea-pig brain.
    Yip J; Chahl LA
    Br J Pharmacol; 1997 Oct; 122(4):715-25. PubMed ID: 9375969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
    Cellier E; Barbot L; Regoli D; Couture R
    Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence for the involvement of tachykinin receptor subtypes in formalin and capsaicin models of pain in mice.
    Santos AR; Calixto JB
    Neuropeptides; 1997 Aug; 31(4):381-9. PubMed ID: 9308027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential induction of c-fos expression in brain nuclei by noxious and non-noxious colonic distension: role of afferent C-fibers and 5-HT3 receptors.
    Mönnikes H; Rüter J; König M; Grote C; Kobelt P; Klapp BF; Arnold R; Wiedenmann B; Tebbe JJ
    Brain Res; 2003 Mar; 966(2):253-64. PubMed ID: 12618348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tachykinin receptor antagonists in experimental neuropathic pain.
    Coudoré-Civiale MA; Courteix C; Eschalier A; Fialip J
    Eur J Pharmacol; 1998 Nov; 361(2-3):175-84. PubMed ID: 9865506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression.
    Chapman V; Buritova J; Honoré P; Besson JM
    J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tachykinin NK1, NK2 and NK3 receptors in the modulation of visceral hypersensitivity in the rat.
    Gaudreau GA; Plourde V
    Neurosci Lett; 2003 Nov; 351(2):59-62. PubMed ID: 14583381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tachykinin NK1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus.
    Hahn MK; Bannon MJ
    Eur J Pharmacol; 1998 May; 348(2-3):155-60. PubMed ID: 9652329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists.
    Mazzone SB; Geraghty DP
    Br J Pharmacol; 2000 Mar; 129(6):1121-31. PubMed ID: 10725260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cardiac activity by tachykinins in the rat substantia nigra.
    Lessard A; Couture R
    Br J Pharmacol; 2001 Dec; 134(8):1749-59. PubMed ID: 11739252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.